Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, LifeStance Health Group Inc (NASDAQ: LFST) closed at $5.84 up 2.82% from its previous closing price of $5.68. In other words, the price has increased by $2.82 from its previous closing price. On the day, 0.85 million shares were traded. LFST stock price reached its highest trading level at $5.895 during the session, while it also had its lowest trading level at $5.75.
Ratios:
For a deeper understanding of LifeStance Health Group Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.22. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on January 03, 2024, initiated with a Underweight rating and assigned the stock a target price of $7.
On May 15, 2023, TD Cowen Downgraded its rating to Market Perform which previously was Outperform and also upped its target price recommendation from $8 to $9.
Morgan Stanley Upgraded its Equal-Weight to Overweight on January 06, 2023, while the target price for the stock was maintained at $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 08 ’24 when Khan Irrevocable Trust LLC bought 160,098 shares for $5.51 per share.
KEVIN M MULLINS bought 300,000 shares of LFST for $1,653,000 on Aug 08 ’24. On Aug 01 ’24, another insider, Qureshi Irrevocable Trust LLC, who serves as the Officer of the company, bought 100 shares for $5.51 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFST now has a Market Capitalization of 2234518528 and an Enterprise Value of 2583650048. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.93 while its Price-to-Book (P/B) ratio in mrq is 1.57. Its current Enterprise Value per Revenue stands at 2.234 whereas that against EBITDA is 453.67.
Stock Price History:
Over the past 52 weeks, LFST has reached a high of $9.20, while it has fallen to a 52-week low of $4.64. The 50-Day Moving Average of the stock is 8.02%, while the 200-Day Moving Average is calculated to be -6.99%.
Shares Statistics:
For the past three months, LFST has traded an average of 1.86M shares per day and 2089130 over the past ten days. A total of 378.73M shares are outstanding, with a floating share count of 111.27M. Insiders hold about 70.92% of the company’s shares, while institutions hold 32.84% stake in the company. Shares short for LFST as of 1722384000 were 14874961 with a Short Ratio of 7.99, compared to 1719532800 on 16007253. Therefore, it implies a Short% of Shares Outstanding of 14874961 and a Short% of Float of 18.6.
Earnings Estimates
At present, 7.0 analysts are actively evaluating the performance of LifeStance Health Group Inc (LFST) in the stock market.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.21 and -$0.26 for the fiscal current year, implying an average EPS of -$0.24. EPS for the following year is -$0.18, with 7.0 analysts recommending between -$0.1 and -$0.23.
Revenue Estimates
For the next quarter, 6 analysts are estimating revenue of $311.37M. There is a high estimate of $313.5M for the next quarter, whereas the lowest estimate is $308.92M.
A total of 8 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $1.23B, while the lowest revenue estimate was $1.21B, resulting in an average revenue estimate of $1.22B. In the same quarter a year ago, actual revenue was $1.06BBased on 8 analysts’ estimates, the company’s revenue will be $1.38B in the next fiscal year. The high estimate is $1.42B and the low estimate is $1.35B.
